← All stocks

HALOZYME THERAPEUTICS, INC.

HALO Scheduled selling only

CIK 0001159036 #857 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$8.48M

$2.05M on a plan · $6.44M straight out of an exercise

Sold at will

$0.00

0 of 11 sales

Net

−$8.48M

$0.00 against sales at will

By person

14 insiders · 11 transactions

83.6×

Helen I. Torley holds 83.6 times base salary in stock. $83.68M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Helen I. Torley last reported holding, valued at $108.99, the price Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Torley Helen

PRESIDENT AND CEO

—

$6.44M (7) scheduled

−$6.44M

767,780

0.6765%

$83.68M

+13.5%

Posard Matthew L.

Director

—

$2.05M (4) scheduled

−$2.05M

58,839

0.0518%

$6.41M

−15.8%

MATSUI CONNIE

Director

—

183,035

0.1613%

$19.95M

−5.4%

LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

—

173,756

0.1531%

$18.94M

0.0%

Snyder Mark Howard

SVP, CHIEF LEGAL OFFICER

—

49,929

0.0440%

$5.44M

+327.5%

Connaughton Bernadette

Director

—

40,418

0.0356%

$4.41M

−13.6%

LaBrosse Nicole

SVP, CHIEF FINANCIAL OFFICER

—

38,494

0.0339%

$4.20M

+148.7%

Henderson Jeffrey William

Director

—

36,572

0.0322%

$3.99M

−31.8%

Miyashita Akiko Moni

Director

—

24,937

0.0220%

$2.72M

+20.1%

DUNCAN BARBARA GAYLE

Director

—

23,715

0.0209%

$2.58M

+50.5%

Krishnan Mahesh

Director

—

14,462

0.0127%

$1.58M

+122.5%

Caudill Cortney

SVP, CHIEF OPERATING OFFICER

—

7,055

0.0062%

$768.93K

−8.1%

Lang James Paul

Director

—

4,685

0.0041%

$510.62K

—

RAMSAY DAVID A

EVP, PRESIDENT, DRUG DELIVERY

—

4,592

0.0040%

$500.49K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Posard Matthew L.

16 Sep 2026

Director

Sold on a plan

4,000

$108.99

$435.96K

Posard Matthew L.

16 Sep 2026

Director

Sold on a plan

8,896

$108.04

$961.12K

Posard Matthew L.

16 Sep 2026

Director

Sold on a plan

3,000

$106.83

$320.48K

Posard Matthew L.

16 Sep 2026

Director

Sold on a plan

3,100

$106.13

$329.01K

Torley Helen

11 Sep 2026

PRESIDENT AND CEO

Sold after exercise

4,508

$107.55

$484.83K

Torley Helen

11 Sep 2026

PRESIDENT AND CEO

Sold after exercise

15,492

$107.15

$1.66M

Torley Helen

10 Sep 2026

PRESIDENT AND CEO

Sold after exercise

5,412

$107.58

$582.23K

Torley Helen

10 Sep 2026

PRESIDENT AND CEO

Sold after exercise

14,588

$107.01

$1.56M

Torley Helen

9 Sep 2026

PRESIDENT AND CEO

Sold after exercise

100

$108.67

$10.87K

Torley Helen

9 Sep 2026

PRESIDENT AND CEO

Sold after exercise

6,596

$107.82

$711.19K

Torley Helen

9 Sep 2026

PRESIDENT AND CEO

Sold after exercise

13,304

$107.22

$1.43M

HALOZYME THERAPEUTICS, INC.

By person

Individual transactions

What was left out